了解状细胞癌中的PI3K/Akt/mTOR信号传导:突变的PIK3CA作为一个例子
Shutao Zheng1, Shuo He1, Yan Liang1
1State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, Xinjiang, People's Republic of China.
皮克3CA突变在状细胞癌 (SCC) 中比腺癌更为普遍. 本综述探讨了SCC中PIK3CA突变的临床意义,重点关注恶性细胞行为,预后和治疗耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 与腺癌相比,PIK3CA突变在状细胞癌 (SCC) 中更频繁.
- 在PIK3CA外体9和20中的热点突变具有临床相关性,但它们在SCC中的意义尚未明确.
- SCC通常发生在暴露于致癌物质的环境中.
研究的目的:
- 审查SCC中PIK3CA突变的临床意义.
- 阐明PIK3CA突变对SCC恶性细胞行为,预后和治疗反应的影响.
- 为了解决PIK3CA突变的文献稀缺性,特别是在SCC中.
主要方法:
- 文献审查专注于涉及SCC.PIK3CA突变的研究.
- 选择性地纳入详细介绍PIK3CA突变及其临床影响的研究.
- 排除在腺癌和其他PI3K-AKT-mTOR通路成员中的PIK3CA研究.
主要成果:
- PIK3CA突变在SCC中很常见,并且与不利的环境因素有关.
- 经常观察到特定的热点突变 (E542K,E545K,H1047L,H1047R).
- 这些突变在SCC中的临床病理学意义需要进一步阐明.
结论:
- PIK3CA突变在SCC.的发病和进展中起着至关重要的作用.
- 了解PIK3CA突变的影响对于SCC患者的预后和治疗策略至关重要.
- 需要进一步的研究,以充分定义PIK3CA突变在SCC管理中的作用.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
